146 related articles for article (PubMed ID: 24478168)
1. Role of VEGF-C gene polymorphisms in susceptibility to hepatocellular carcinoma and its pathological development.
Hsieh MC; Hsu HT; Hsiao PC; Yang SF; Yeh CB; Bien MY; Lin CH; Chien MH
J Clin Lab Anal; 2014 May; 28(3):237-44. PubMed ID: 24478168
[TBL] [Abstract][Full Text] [Related]
2. Impact of VEGF-C gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan.
Chien MH; Liu YF; Hsin CH; Lin CH; Shih CH; Yang SF; Cheng CW; Lin CW
PLoS One; 2013; 8(4):e60283. PubMed ID: 23593187
[TBL] [Abstract][Full Text] [Related]
3. Associations of VEGF-C genetic polymorphisms with urothelial cell carcinoma susceptibility differ between smokers and non-smokers in Taiwan.
Tung MC; Hsieh MJ; Wang SS; Yang SF; Chen SS; Wang SW; Lee LM; Lee WJ; Chien MH
PLoS One; 2014; 9(3):e91147. PubMed ID: 24608123
[TBL] [Abstract][Full Text] [Related]
4. Survivin T9809C, an SNP located in 3'-UTR, displays a correlation with the risk and clinicopathological development of hepatocellular carcinoma.
Hsieh YS; Tsai CM; Yeh CB; Yang SF; Hsieh YH; Weng CJ
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S625-33. PubMed ID: 22052111
[TBL] [Abstract][Full Text] [Related]
5. Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.
Shin SP; Kim NK; Kim JH; Lee JH; Kim JO; Cho SH; Park H; Kim MN; Rim KS; Hwang SG
World J Gastroenterol; 2015 Dec; 21(46):13064-72. PubMed ID: 26672513
[TBL] [Abstract][Full Text] [Related]
6. Effects of EZH2 polymorphisms on susceptibility to and pathological development of hepatocellular carcinoma.
Yu YL; Su KJ; Hsieh YH; Lee HL; Chen TY; Hsiao PC; Yang SF
PLoS One; 2013; 8(9):e74870. PubMed ID: 24040354
[TBL] [Abstract][Full Text] [Related]
7. Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma.
Chen TY; Li YC; Liu YF; Tsai CM; Hsieh YH; Lin CW; Yang SF; Weng CJ
Ann Surg Oncol; 2011 Aug; 18(8):2348-56. PubMed ID: 21298348
[TBL] [Abstract][Full Text] [Related]
8. CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.
Chou YE; Hsieh MJ; Chiou HL; Lee HL; Yang SF; Chen TY
Biomed Res Int; 2014; 2014():231474. PubMed ID: 24971320
[TBL] [Abstract][Full Text] [Related]
9.
Dai C; Kuo SJ; Hu SL; Tsai CH; Huang YL; Huang CC; Wang L; Xu G; Su CM; Tang CH
Int J Med Sci; 2019; 16(10):1397-1403. PubMed ID: 31692815
[TBL] [Abstract][Full Text] [Related]
10. Impacts of CCL4 gene polymorphisms on hepatocellular carcinoma susceptibility and development.
Wang B; Chou YE; Lien MY; Su CM; Yang SF; Tang CH
Int J Med Sci; 2017; 14(9):880-884. PubMed ID: 28824325
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphisms associated with metastatic tumour antigen 1 overexpression in patients with hepatocellular carcinoma.
Lee SH; Chung YH; Kim JA; Lee D; Jin YJ; Shim JH; Jang MK; Cho EY; Shin ES; Lee JE; Park NH; Yu E; Lee YJ
Liver Int; 2012 Mar; 32(3):457-66. PubMed ID: 22098246
[TBL] [Abstract][Full Text] [Related]
12. Association between Interleukin-18 Polymorphisms and Hepatocellular Carcinoma Occurrence and Clinical Progression.
Lau HK; Hsieh MJ; Yang SF; Wang HL; Kuo WH; Lee HL; Yeh CB
Int J Med Sci; 2016; 13(7):556-61. PubMed ID: 27429592
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Chitinase 3-Like 1 Single Nucleotide Polymorphisms with Hepatocellular Carcinoma in Taiwan.
Huang WS; Lin HY; Yeh CB; Chen LY; Chou YE; Yang SF; Liu YF
Int J Med Sci; 2017; 14(2):136-142. PubMed ID: 28260989
[TBL] [Abstract][Full Text] [Related]
14. Association of VEGFA polymorphisms with susceptibility and clinical outcome of hepatocellular carcinoma in a Chinese Han population.
Liu F; Luo L; Wei Y; Wang W; Wen T; Yang J; Xu M; Li B
Oncotarget; 2017 Mar; 8(10):16488-16497. PubMed ID: 28147320
[TBL] [Abstract][Full Text] [Related]
15. The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility.
Junjie X; Songyao J; Minmin S; Yanyan S; Baiyong S; Xiaxing D; Jiabin J; Xi Z; Hao C
BMC Cancer; 2012 Feb; 12():57. PubMed ID: 22309608
[TBL] [Abstract][Full Text] [Related]
16. Association of CTLA-4, TNF alpha and IL 10 polymorphisms with susceptibility to hepatocellular carcinoma.
Wang JJ; Wang ZB; Tan TC
Scand J Immunol; 2019 Dec; 90(6):e12819. PubMed ID: 31448426
[TBL] [Abstract][Full Text] [Related]
17. The role of vascular endothelial growth factor -634 G/C and its soluble receptor on chronic liver disease and hepatocellular carcinoma.
Ratnasari N; Nurdjanah S; Sadewa AH; Hakimi M
Arab J Gastroenterol; 2016 Jun; 17(2):61-6. PubMed ID: 27426958
[TBL] [Abstract][Full Text] [Related]
18. Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population.
Xie Q; Chen Z; Xia L; Zhao Q; Yu H; Yang Z
Gene; 2018 Oct; 674():188-194. PubMed ID: 29940275
[TBL] [Abstract][Full Text] [Related]
19. Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development.
Chen TP; Lee HL; Huang YH; Hsieh MJ; Chiang WL; Kuo WH; Chou MC; Yang SF; Yeh CB
Tumour Biol; 2016 Feb; 37(2):2067-74. PubMed ID: 26341495
[TBL] [Abstract][Full Text] [Related]
20. Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients.
Saad H; Zahran MA; Hendy O; Abdel-Samiee M; Bedair HM; Abdelsameea E
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3725-3734. PubMed ID: 33369474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
